LP1 from C Induces Autophagy, Apoptosis and Reduces Metastasis in Human Gastric Cancer Cell Line SGC-7901
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Present study aimed to elucidate the anticancer effect and the possible molecular mechanism underlying the action of Latcripin 1 (LP1), from the mushroom strain C against gastric cancer cell lines SGC-7901 and BGC-823. Cell viability was measured by Cell Counting Kit-8 (CCK-8); morphological changes were observed by phase contrast microscope; autophagy was determined by transmission electron microscope and fluorescence microscope. Apoptosis and cell cycle were assessed by flow cytometer; wound-healing, transwell migration and invasion assays were performed to investigate the effect of LP1 on gastric cancer cell's migration and invasion. Herein, we found that LP1 resulted in the induction of autophagy by the formation of autophagosomes and conversion of light chain 3 (LC3I into LC3II. LP1 up-regulated the expression level of autophagy-related gene (Atg7, Atg5, Atg12, Atg14) and Beclin1; increased and decreased the expression level of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) proteins respectively, along with the activation of Caspase-3. At lower-doses, LP1 have shown to arrest cells in the S phase of the cell cycle and decreased the expression level of matrix metalloproteinase MMP-2 and MMP-9. In addition, it has also been shown to regulate the phosphorylation of one of the most hampered gastric cancer pathway, that is, protein kinase B/mammalian target of rapamycin (Akt/mTOR) channel and resulted in cell death. These findings suggested LP1 as a potential natural anti-cancer agent, for exploring the gastric cancer therapies and as a contender for further in vitro and in vivo investigations.
Tian L, Chen X, Cao L, Zhang L, Chen J BMC Complement Med Ther. 2022; 22(1):233.
PMID: 36056333 PMC: 9438347. DOI: 10.1186/s12906-022-03703-0.
Rahman M, Ahmed K, Rahman M, Park M, Kim B Front Pharmacol. 2022; 12:813703.
PMID: 35153766 PMC: 8834883. DOI: 10.3389/fphar.2021.813703.
Kang S, Hwang D, Shin S, Park J, Kim M, Rahman M Cancers (Basel). 2021; 13(18).
PMID: 34572730 PMC: 8469857. DOI: 10.3390/cancers13184502.
Balakrishnan B, Liang Q, Fenix K, Tamang B, Hauben E, Ma L Nutrients. 2021; 13(8).
PMID: 34444724 PMC: 8401741. DOI: 10.3390/nu13082564.
Chen X, Yue W, Tian L, Li N, Chen Y, Zhang L BMC Complement Med Ther. 2021; 21(1):137.
PMID: 33964908 PMC: 8106854. DOI: 10.1186/s12906-021-03301-6.